Document Detail


Laparotomy-staged IA versus IIA Hodgkin's disease. A comparative study with evaluation of prognostic factors for stage IIA disease.
MedLine Citation:
PMID:  4016677     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Ninety-one laparotomy-staged (LAP) IA and IIA Hodgkin's disease (HD) patients were analyzed to evaluate the prognostic significance of stage, mediastinal status, extranodal disease and histology. Forty IA patients were treated with radiotherapy (XRT) only; of 51 IIA patients, 44 received XRT only and 7 had additional chemotherapy. Disease-free survival (DFS) at 5 and 10 years was 81% and 70%, respectively, with overall survival (S) of 93% and 86%, respectively. Disease-free survival for IA patients (93% at 5 and 10 years) was significantly superior to IIA (73% at 5 years, 52% at 10 years). Survival differences were not statistically significant. For IIA patients receiving XRT only, large mediastinal disease was an adverse factor for DFS. Small mediastinal disease in IIA was significantly better than no mediastinal disease. For the whole group of LAP IA and IIA treated by XRT only, three prognostic groups were identified: (1) Stage IA and Stage IIA with mediastinal disease, but less than 7.5 cm in width was highly favorable with less than 10% relapse; (2) Stage IIA nonmediastinal had an intermediate prognosis with relapse in about 33%; (3) Stage IIA large mediastinal (greater than or equal to 7.5 cm) had an unfavorable DFS with relapse in about 55%. The third group contained a highly unfavorable subset with mediastinal masses greater than 10 cm, all of whom relapsed. Salvage therapy was successful in 60% of relapsing patients. In the context of relatively effective salvage therapy, the role of adjuvant chemotherapy in adverse prognostic groups is discussed and it is concluded that the only clearly justifiable use for adjuvant chemotherapy is in patients with massive (greater than 10 cm) mediastinal adenopathy.
Authors:
G Zagars; P Rubin
Related Documents :
11765187 - Pleuropulmonary blastoma in a child presenting with pneumothorax.
7614797 - Mediastinal lymph node enlargement and splenomegaly in primary hypogammaglobulinaemia.
21750357 - Surgical treatment of patients with disseminated ewing sarcoma in our clinical experience.
17996977 - Prolonged survival of a woman with lung cancer diagnosed and treated with chemotherapy ...
20584717 - Epistaxis or epiphora as a sign for extension of a conjunctival melanoma. a series of s...
10568817 - Prognostic benefit in cytoreductive surgery for curatively unresectable hepatocellular ...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Cancer     Volume:  56     ISSN:  0008-543X     ISO Abbreviation:  Cancer     Publication Date:  1985 Aug 
Date Detail:
Created Date:  1985-08-26     Completed Date:  1985-08-26     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  0374236     Medline TA:  Cancer     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  864-73     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Combined Modality Therapy
Female
Hodgkin Disease / drug therapy,  mortality,  pathology*,  radiotherapy
Humans
Laparotomy*
Male
Neoplasm Recurrence, Local
Neoplasm Staging / methods*
Prognosis
Radiation Injuries
Time Factors
Grant Support
ID/Acronym/Agency:
CA 11051/CA/NCI NIH HHS

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Alveolar rhabdomyosarcoma of the female genitalia.
Next Document:  Renal glomerulopathies associated with Hodgkin's disease.